DK261289D0 - Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser - Google Patents

Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser

Info

Publication number: DK261289D0
Authority: DK; Denmark
Prior art keywords: image; compounds; properties; condensed; diazepines
Prior art date: 1988-05-30

Application number

DK261289A

Other languages

English (en)

Other versions

DK261289A (da

Inventor

Wolfhard Engel

Wolfgang Eberlein

Gerhard Mihm

Guenter Trummlitz

Norbert Mayer

Adriaan De Jonge

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-05-30

Filing date

1989-05-29

Publication date

1989-05-29

1989-05-29 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1989-05-29 Publication of DK261289D0 publication Critical patent/DK261289D0/da

1989-12-01 Publication of DK261289A publication Critical patent/DK261289A/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Macromonomer-Based Addition Polymer (AREA)
Thermal Transfer Or Thermal Recording In General (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK261289A 1988-05-30 1989-05-29 Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser DK261289A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3818299A DE3818299A1 (de)	1988-05-30	1988-05-30	Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number	Publication Date
DK261289D0 true DK261289D0 (da)	1989-05-29
DK261289A DK261289A (da)	1989-12-01

Family

ID=6355412

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK261289A DK261289A (da)	1988-05-30	1989-05-29	Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser

Country Status (17)

Country	Link
US (1)	US5006522A (da)
EP (1)	EP0344543B1 (da)
JP (1)	JPH0228163A (da)
KR (1)	KR900018101A (da)
AT (1)	ATE78479T1 (da)
AU (1)	AU617814B2 (da)
DD (1)	DD283822A5 (da)
DE (2)	DE3818299A1 (da)
DK (1)	DK261289A (da)
FI (1)	FI892596A (da)
HU (1)	HU203887B (da)
IL (1)	IL90418A0 (da)
NO (1)	NO169539C (da)
NZ (1)	NZ229307A (da)
PT (1)	PT90677B (da)
SU (1)	SU1731057A3 (da)
ZA (1)	ZA894048B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3726908A1 (de) *	1987-08-13	1989-02-23	Thomae Gmbh Dr K	Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE161535T1 (de) *	1989-04-20	1998-01-15	Boehringer Ingelheim Pharma	6,11-dihydro-5h-pyrido(2,3-b)(1,5)benzodiazepin 5-one und thione und ihre verwendung für die vorbeugung oder behandlung von aids
DE3919076A1 (de) *	1989-06-10	1990-12-13	Thomae Gmbh Dr K	Mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung
ATE221067T1 (de) *	1993-04-05	2002-08-15	Pharmaceutical Discovery Corp	Pyrido(2,3-b)(1,4)benzodiazepinone als m2- rezeptorligand zur behandlung neurologischer störungen
US5561127A (en) *	1994-12-19	1996-10-01	Allelix Biopharmaceuticals, Inc.	Muscarinic receptor ligands
JP3521569B2 (ja) *	1995-09-05	2004-04-19	ブラザー工業株式会社	印字制御装置
FR2850654A1 (fr) *	2003-02-03	2004-08-06	Servier Lab	Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0812849A2 (pt) *	2007-07-02	2014-12-09	Ac Immune Sa	Composto ou uma composição farmacêutica, e, métodos para usar um composto, para reduzir a carga de placa b-amilóide e/ou inibir a formação das placas b-amilóides e/ou retardar o aumento da carga amilóide no cérebro de um animal, para tratar uma condição, e, para reter ou aumentar a capacidade de memória cognitiva em um animal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3150125A (en) *	1959-09-22	1964-09-22	Wander Ag Dr A	5-(basic substituted)-10, 11-dihydro-11-oxo-5h-dibenzo[b, e][1, 4]diazepine compounds
US3105125A (en) *	1959-10-30	1963-09-24	Bell Telephone Labor Inc	Power separation filter
EP0213293B1 (de) *	1985-06-27	1992-01-02	Dr. Karl Thomae GmbH	In 11-Stellung substituierte 5,11-Dihydro-6H-pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zur ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4749788A (en) *	1987-04-13	1988-06-07	A. H. Robins Company, Incorporated	Process for the preparation of aryl-pyrido(1,4) benzodiazepines
DE3819444A1 (de) *	1988-06-08	1989-12-14	Thomae Gmbh Dr K	Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3820346A1 (de) *	1988-06-15	1989-12-21	Thomae Gmbh Dr K	Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

1988
- 1988-05-30 DE DE3818299A patent/DE3818299A1/de not_active Withdrawn
1989
- 1989-05-15 SU SU894614115A patent/SU1731057A3/ru active
- 1989-05-19 EP EP89109040A patent/EP0344543B1/de not_active Expired - Lifetime
- 1989-05-19 DE DE8989109040T patent/DE58901872D1/de not_active Expired - Lifetime
- 1989-05-19 AT AT89109040T patent/ATE78479T1/de not_active IP Right Cessation
- 1989-05-26 NZ NZ229307A patent/NZ229307A/en unknown
- 1989-05-26 IL IL90418A patent/IL90418A0/xx unknown
- 1989-05-29 PT PT90677A patent/PT90677B/pt not_active IP Right Cessation
- 1989-05-29 HU HU892717A patent/HU203887B/hu not_active IP Right Cessation
- 1989-05-29 JP JP1135700A patent/JPH0228163A/ja active Pending
- 1989-05-29 DK DK261289A patent/DK261289A/da not_active Application Discontinuation
- 1989-05-29 KR KR1019890007154A patent/KR900018101A/ko not_active Application Discontinuation
- 1989-05-29 NO NO892152A patent/NO169539C/no unknown
- 1989-05-29 FI FI892596A patent/FI892596A/fi not_active Application Discontinuation
- 1989-05-29 DD DD89329002A patent/DD283822A5/de not_active IP Right Cessation
- 1989-05-29 ZA ZA894048A patent/ZA894048B/xx unknown
- 1989-05-30 AU AU35850/89A patent/AU617814B2/en not_active Ceased
- 1989-05-30 US US07/358,740 patent/US5006522A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NZ229307A (en)	1990-11-27
ZA894048B (en)	1991-02-27
EP0344543A2 (de)	1989-12-06
DK261289A (da)	1989-12-01
DE58901872D1 (de)	1992-08-27
JPH0228163A (ja)	1990-01-30
DE3818299A1 (de)	1989-12-07
HUT50343A (en)	1990-01-29
NO169539C (no)	1992-07-08
NO892152L (no)	1989-12-01
NO892152D0 (no)	1989-05-29
KR900018101A (ko)	1990-12-20
HU203887B (en)	1991-10-28
AU617814B2 (en)	1991-12-05
EP0344543B1 (de)	1992-07-22
FI892596A0 (fi)	1989-05-29
SU1731057A3 (ru)	1992-04-30
IL90418A0 (en)	1990-01-18
FI892596A (fi)	1989-12-01
PT90677A (pt)	1989-11-30
ATE78479T1 (de)	1992-08-15
AU3585089A (en)	1989-11-30
PT90677B (pt)	1994-11-30
US5006522A (en)	1991-04-09
EP0344543A3 (en)	1990-08-22
DD283822A5 (de)	1990-10-24
NO169539B (no)	1992-03-30

Publication	Publication Date	Title
Leipsic	1901	Developmental (myelogenetic) localisation of the cerebral cortex in the human subject.
DK0812190T3 (da)	2005-04-11	R-enantiomer af N-propargyl-1-aminoindan til behandling af forskellige sygdomme og mesylat, esulat og sulfat deraf
KR890701107A (ko)	1989-12-19	알쯔하이머 병 치료용 화합물들
ES2078440T3 (es)	1995-12-16	Compuestos farmaceuticos.
DE69012591D1 (de)	1994-10-27	Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen.
BE882833A (fr)	1980-08-18	Sels mixtes d'acides amines essentiels ou semi-essentiels et de leurs analogues exempts d'azote, en utilisant pour traiter des desordres renaux
TNSN88096A1 (fr)	1990-07-10	Nouveau n-(1-alkyl-3-hydroxy-4-piperidyl)
DK261289A (da)	1989-12-01	Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser
NO921447L (no)	1992-10-13	Kondenserte diazepinoner, fremgangsmaate for deres fremstilling, og midler som inneholder disse forbindelser
ATE285773T1 (de)	2005-01-15	Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
DK0561597T3 (da)	1997-01-20	Physostigminderivater, deres anvendelse og farmaceutiske præparater indeholdende disse
NO161494C (no)	1989-08-23	Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner.
DE69307702D1 (de)	1997-03-06	Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
ATE137752T1 (de)	1996-05-15	5-aminocarbonyl-5h-dibenzo-a,d>cyclohepten-5,10 imine zur behandlung von epilepsie und kokainsucht
NO961180L (no)	1996-03-22	Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom

Legal Events

Date	Code	Title	Description
1994-01-24	AHB	Application shelved due to non-payment